- Home
- / Pivotal Therapeutics
Pivotal Therapeutics
Stock Price
$0
2024-05-24
Market Capitalization
$172.4 K
2024-05-24
Pivotal Therapeutics Summary
Company Summary
- Overview
- Pivotal Therapeutics is a pharmaceutical company developing Omega-3 therapies for cardiovascular disease and overall health. It offers VASCAZEN, a medical food for the treatment of an Omega-3 deficiency in patients with cardiovascular disease and OMAZEN, a pure Omega-3 for the maintenance of health.
- Type
- Public
- Status
- Active
- Founded
- 2010
- HQ
- Vaughan, CA | view all locations
- Cybersecurity rating
Table of Contents
Key People
George Jackowski, Founder, Chairman, & CSO
Rachelle MacSweeney, Founder, President & COO
LocationsView all
3 locations detected
Vaughan, ON HQ
Canada
10-81 Zenway Blvd, Woodbridge
Boca Raton, FL
United States
3651 FAU Boulevard #400
Vaughan, ON
Canada
17-30 Pennsylvania Ave, Concord
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026